PubMed Health⌕ Search

Biomedical subjects

N L Keltner

Publications and source records attributed to N L Keltner.

35 records · Page 2Linked to original sources

Neuroreceptor function and psychopharmacologic response.

Psychiatric diagnoses are imprecise and that imprecision flows from current diagnostic criteria. Essentially psychiatric conditions are viewed, reported, and studied from a syndromal perspective. That is, if sufficient signs and symptoms are present, then a specific diagnosis can be made. This relative "softness" contrasts with more pathophysiology-based diagnostic criteria used by our medical-surgical colleagues. As psychiatry and psychiatric nursing move toward a more scientific base for diagnosis, a greater emphasis has been placed on psychobiological dimensions of illness. The most aggressive approach to treating the psychobiological "causes" of mental disorders is the psychopharmacological approach. Essentially all psychotropic drugs affect neurotransmitter systems, however it is becoming clear that effects on receptors may be the most significant aspect of drug therapy. This article reviews receptor function and specific receptors known to be important in both the pathology and treatment of mental disorders.

Antipsychotic Agents↗

Pharmacokinetics and psychopharmacology: application to the geropsychiatric patient.

Understanding pharmacokinetics is an important step in the confident administration of psychotropic drugs. Changes in pharmacokinetics have particular implications for the geropsychiatric patient who will experience a variety of physiological changes that could potentially affect the intensity and duration of drug effects.

Aged↗

Risperidone: the search for a better antipsychotic.

Risperidone, the latest agent in the continuing search for a better antipsychotic drug, seems to be an important addition to our treatment armamentarium for several reasons. First, risperidone is as effective as traditional antipsychotics for treating schizophrenia and perhaps more effective for treating refractory schizophrenia. Second, and related to the first point, risperidone is effective in the treatment of the negative symptoms of schizophrenia. Third, risperidone has a superior side-effect profile causing relatively few, if any, EPSEs. Fourth, risperidone may have an antidyskinetic property that, rather than simply not causing tardive dyskinesia, may actually improve those symptoms.

Antipsychotic Agents↗

Nature vs. nurture: two brothers with schizophrenia.

TOPIC: The nature vs. nurture argument as it pertains to two brothers. PURPOSE: To explore the synergistic effects of heritability and environment in the cases of two brothers with schizophrenia. SOURCES: Review of the literature and the authors' clinical experience. CONCLUSIONS: The nature vs. nurture dichotomy may not be as relevant as looking at the interaction between these two forces.

Environment↗

Neuroanatomy and physiology in modern child psychiatric nursing.

TOPIC: Brain anatomy and brain function pertinent to clinical practice in child and adolescent psychiatric nursing. PURPOSE: Over the past two decades psychiatry has increasingly turned to biological explanations for the etiology of mental disorders. In addition, public awareness of neurobiology has been kindled by a steady flow of articles in the media about the brain. Finally, there has been a tremendous proliferation of psychopharmacological agents used in the treatment of mental disorders in both adult and pediatric populations. Hence, nurses are increasingly expected to employ a knowledge base that embraces the fundamentals of neuroscience. SOURCES: This article briefly reviews current information about brain anatomy and function in order to provide a foundation for current practice. CONCLUSION: Contemporary psychiatric nursing practice all but requires nurses to acquire a basic understanding of neuroanatomy and physiology.

Adult↗

Culture as a variable in drug therapy.

Few studies exist on culture as a variable in psychopharmacological intervention and response. Differences exist, but are they genetic? environmental? social?

Cultural Characteristics↗

Drugs used for cognitive symptoms of Alzheimer's disease.

AD is a devastating disease that is increasing in real numbers as our population ages. The toll on individuals, families, health care, and society will continue to escalate unless more effective treatment approaches are developed. To date, the most effective treatments are those that increase brain ACh levels by retarding the enzymatic breakdown of this neurotransmitter. These agents have proved modestly effective but are far from being the answer to AD. Further, when these drugs are withdrawn, patients rapidly decompensate to the state of disability suffered by those receiving placebo, indicating the deteriorative process continues unabated. The long-term effects on cognition of these drugs also is not known, but most clinicians are not overly optimistic. Other pharmacologic approaches include vitamin E, ginkgo biloba, estrogen, and the nonsteroidal anti-inflammatory drugs. Clinical trials do not robustly support their efficacy at this time, but there are numerous anecdotal reports to promote any or all of these approaches. Newer strategies under study include antiamyloid agents and nootropics (which enhance neuronal metabolic activity). The value of these approaches remains to be confirmed.

Aged↗